Association between adenotonsillar hypertrophy, tonsillitis and painful crises in sickle cell disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier Editora Ltda Country of Publication: Brazil NLM ID: 2985188R Publication Model: Print Cited Medium: Internet ISSN: 1678-4782 (Electronic) Linking ISSN: 00217557 NLM ISO Abbreviation: J Pediatr (Rio J) Subsets: MEDLINE
    • Publication Information:
      Publication: Rio de Janeiro, Brazil : Elsevier Editora Ltda
      Original Publication: Rio de Janeiro.
    • Subject Terms:
      Adenoids/*pathology ; Anemia, Sickle Cell/*complications ; Pain/*complications ; Palatine Tonsil/*pathology ; Tonsillitis/*complications; Adolescent ; Anemia, Sickle Cell/blood ; Brazil/epidemiology ; Child ; Epidemiologic Methods ; Female ; Hemoglobins/analysis ; Humans ; Hypertrophy/epidemiology ; Hypertrophy/pathology ; Male ; Pain/epidemiology ; Tonsillitis/epidemiology
    • Abstract:
      Objectives: To determine the prevalence of obstructive adenotonsillar hypertrophy in children and adolescents with sickle cell anemia; to investigate possible association between the presence of more than five episodes of tonsillitis in the last 12 months and episodes of painful crises in the same period; and to compare the mean annual hemoglobin level in children and adolescents with and without obstructive adenotonsillar hypertrophy.
      Methods: Prospective, observational, cross-sectional study involving 85 children and adolescents with sickle cell anemia. All patients answered a questionnaire and underwent a standard otolaryngology examination, including endoscopic endonasal approach. The diagnosis of obstructive adenotonsillar hypertrophy was made according to the Brodsky scale.
      Results: The prevalence of obstructive adenotonsillar hypertrophy was 55.3%. Obstructive adenotonsillar hypertrophy was associated with history of difficulty in eating (76.7 vs. 23.5%, p = 0.003), presence of more than five episodes of tonsillitis in the last 12 months (70.6 vs. 29.4%, p = 0.021), loud snoring (73.0 vs. 27.0%, p = 0.004), and sleep apnea (71.8 vs. 28.2%, p = 0.005). Patients with obstructive adenotonsillar hypertrophy had more episodes of recurrent upper airway tract infection (62.5 vs. 37.5; p = 0.010). The presence of more than five episodes of tonsillitis in the last 12 months was associated with episodes of painful crises (median = 12 vs. 2, p = 0.017). There was no significant difference between mean annual hemoglobin levels of patients with obstructive adenotonsilar hypertrophy vs. nonobstructive adenotonsillar hypertrophy: 7.6 vs. 8.2 g/dL, p = 0.199.
      Conclusions: The prevalence of obstructive adenotonsillar hypertrophy was 55.3% in children and adolescents with sickle cell anemia; the presence of more than five episodes of tonsillitis in the last 12 months was associated with episodes of painful crises in the same period; and there was no difference in the mean annual hemoglobin value among those with or without obstructive adenotonsillar hypertrophy.
    • Accession Number:
      0 (Hemoglobins)
    • Publication Date:
      Date Created: 20090604 Date Completed: 20091123 Latest Revision: 20200413
    • Publication Date:
      20221213
    • Accession Number:
      10.2223/JPED.1898
    • Accession Number:
      19492171